BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1541824)

  • 1. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity.
    Murray HW; Squires KE; Miralles CD; Stoeckle MY; Granger AM; Granelli-Piperno A; Bogdan C
    J Immunol; 1992 Mar; 148(6):1858-63. PubMed ID: 1541824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
    Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role and effect of IL-2 in experimental visceral leishmaniasis.
    Murray HW; Miralles GD; Stoeckle MY; McDermott DF
    J Immunol; 1993 Jul; 151(2):929-38. PubMed ID: 8335921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
    Squires KE; Schreiber RD; McElrath MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1989 Dec; 143(12):4244-9. PubMed ID: 2512353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
    Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
    J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
    Murray HW; Moreira AL; Lu CM; DeVecchio JL; Matsuhashi M; Ma X; Heinzel FP
    J Infect Dis; 2003 Aug; 188(3):458-64. PubMed ID: 12870129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice.
    Cenci E; Romani L; Vecchiarelli A; Puccetti P; Bistoni F
    J Immunol; 1990 Jun; 144(11):4333-9. PubMed ID: 1971296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and effect of TNF-alpha in experimental visceral leishmaniasis.
    Tumang MC; Keogh C; Moldawer LL; Helfgott DC; Teitelbaum R; Hariprashad J; Murray HW
    J Immunol; 1994 Jul; 153(2):768-75. PubMed ID: 8021511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of innate immune cells in protection against Toxoplasma gondii at inflamed site.
    Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Himeno K
    J Med Invest; 2001 Feb; 48(1-2):73-80. PubMed ID: 11286020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector role of blood monocytes in experimental visceral leishmaniasis.
    Cervia JS; Rosen H; Murray HW
    Infect Immun; 1993 Apr; 61(4):1330-3. PubMed ID: 8454335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
    Engwerda CR; Smelt SC; Kaye PM
    Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
    Sherwood ER; Varma TK; Fram RY; Lin CY; Koutrouvelis AP; Toliver-Kinsky TE
    Clin Sci (Lond); 2001 Dec; 101(6):541-50. PubMed ID: 11724637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
    Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmonella abortusovis infection in susceptible BALB/cby mice: importance of Lyt-2+ and L3T4+ T cells in acquired immunity and granuloma formation.
    Guilloteau L; Buzoni-Gatel D; Bernard F; Lantier I; Lantier F
    Microb Pathog; 1993 Jan; 14(1):45-55. PubMed ID: 8321117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
    Giovarelli M; Santoni A; Jemma C; Musso T; Giuffrida AM; Cavallo G; Landolfo S; Forni G
    J Immunol; 1988 Oct; 141(8):2831-6. PubMed ID: 3139768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.